Related content

Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics

By Arab-Alameddine Mona   Déécosterd Laurent Arhtur   Buclin Thierry   Telenti Amalio   Csajka Chantal  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 5, 2011-05 ,pp. : 609-622

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy

By Vidal Francesc   Domingo Pere   Viladés Consuelo   Peraire Joaquim   Arnedo Mireia   Alcamí José   Leal Manuel   Villarroya Francesc   Gatell Josep Ma  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 11, 2011-11 ,pp. : 1365-1382

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients

By  

Current Pharmaceutical Design, Vol. 16, Iss. 30, 2010-10 ,pp. : 3379-3389

Bentham Science Publishers

Access to resources Recommend Favorite

Sex differences in pharmacokinetics and toxicity of antiretroviral therapy

By Umeh Obiamiwe C   Currier Judith S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 2, 2006-04 ,pp. : 273-283

Informa Healthcare

Access to resources Recommend Favorite

Surrogate Markers as a Guide to Evaluate Response to Antiretroviral Therapy

By  

Current Medicinal Chemistry, Vol. 10, Iss. 5, 2003-03 ,pp. : 349-365

Bentham Science Publishers

Access to resources Recommend Favorite